Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparative effectiveness of ocrelizumab in subgroups of patients with multiple sclerosis: a multi-registry observational cohort study.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

Immature CD10<sup>low</sup> blood neutrophils are enriched in people with multiple sclerosis.

Frontiers in immunology·2026
Same author

PLANeT: Understanding and leveraging the genome of land plants for a sustainable future.

Cell·2026
Same author

Predicting disease progression in multiple sclerosis with clinically accessible information and technology.

Journal of neurology·2026
Same author

Preserving Neurological Function in People at High and Low Risk of Aggressive Multiple Sclerosis: An Observational Cohort Study.

CNS drugs·2026
Same author

Comparative effectiveness of anti-CD20 therapies and S1P receptor modulators in late-onset multiple sclerosis: real-world evidence from the MSBase registry.

Therapeutic advances in neurological disorders·2026

Related Experiment Video

Updated: Jun 12, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Hypothalamic lesions in multiple sclerosis.

Wei Qiu1, Sonja Raven, Jing-Shan Wu

  • 1Centre for Neuromuscular and Neurological Disorders, University of Western Australia, Perth, Western Australia, Australia.

Journal of Neurology, Neurosurgery, and Psychiatry
|June 16, 2010
PubMed
Summary
This summary is machine-generated.

Hypothalamic lesions are more common in multiple sclerosis (MS) patients than previously thought. These lesions, identified via conventional MRI, were not associated with NMO-IgG antibodies.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Related Experiment Videos

Last Updated: Jun 12, 2026

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

Area of Science:

  • Neurology
  • Radiology
  • Immunology

Background:

  • Multiple sclerosis (MS) is a chronic demyelinating disease affecting the central nervous system.
  • The hypothalamus, a key brain region, is rarely studied in MS.
  • Conventional MRI (cMRI) protocols are standard for MS diagnosis.

Purpose of the Study:

  • To quantify the prevalence of hypothalamic lesions in MS patients.
  • To investigate the association between hypothalamic lesions and disease activity.
  • To determine if hypothalamic lesions in MS are linked to NMO-IgG antibodies.

Main Methods:

  • Retrospective review of brain cMRI scans from 105 MS patients and 12 with longitudinal extensive myelopathy (LEM).
  • Analysis of lesion frequency in stable vs. active MS groups.
  • NMO-IgG antibody testing in patients with hypothalamic lesions.

Main Results:

  • Hypothalamic lesions were detected in 13.3% of MS patients.
  • A trend towards higher frequency in active MS (18.2%) versus stable MS (8.0%) was observed, not statistically significant (p=0.13).
  • No hypothalamic lesions were found in LEM patients; none of the MS patients with hypothalamic lesions tested positive for NMO-IgG.

Conclusions:

  • Hypothalamic lesions in MS are more prevalent than previously reported.
  • Hypothalamic lesions in MS are not associated with NMO-IgG antibodies.
  • Further research may elucidate the clinical significance of hypothalamic lesions in MS.